Georgia Erbez | Chief Business Officer and CFO |
John P. Walker | CEO |
Donald Kellerman | VP, Clinical Development and Medical Affairs |
Charles C. Duncan | Piper Jaffray |
Good day, ladies and gentlemen, and welcome to the Zosano Pharma Third Quarter 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to Georgia Erbez, Chief Business Officer and Chief Financial Officer.